Impaired erythrocyte NAD synthesis: a metabolic abnormality in thalassemia.
We have recently demonstrated that phosphoribosylpyrophosphate (PRPP) synthetase activity is decreased in RBC from individuals with thalassemia minor. Because NAD biosynthesis requires PRPP, the product of the PRPP synthetase reaction, we have investigated NAD synthesis in thalassemic RBC. NAD synthesis was measured in intact RBC both by following the accumulation of unlabeled NAD and by following the incorporation of 14C-nicotinic acid into NAD. Using both assay systems, we demonstrate that NAD synthesis is decreased significantly in thalassemic RBC compared to either normal or high reticulocyte red cells. Although this suggested that NAD content should be decreased in thalassemic RBC, no significant difference in NAD content was found among thalassemic, normal, or high reticulocyte red cells. Mechanisms for the lack of a significant decrease in NAD content in thalassemic RBC are discussed. These results indicate that NAD synthesis is impaired in thalassemic RBC possibly as a result of their decrease in PRPP synthetase activity. Our data provide evidence that thalassemic RBC have secondary metabolic abnormalities in addition to their primary defect in hemoglobin synthesis.
Department of Medicine, Harbor-UCLA Medical Center, University of California at Los Angeles School of Medicine, Torrance 90502.
C R
CR
Zerez
K R
KR
Tanaka
D002452:Cell Count; D004912:Erythrocytes / Q000201:enzymology*; D006801:Humans; D009243:NAD / Q000096:biosynthesis / Q000097:blood*; D009525:Niacin / Q000378:metabolism; D012016:Reference Values; D012156:Reticulocytes / Q000166:cytology; D013789:Thalassemia / Q000097:blood / Q000201:enzymology*
D009243:NAD; D009525:Niacin